- Home
- Equipment
- south korea
- drawing blood
Refine by
Drawing Blood Equipment Supplied In South Korea
13 equipment items found
Manufactured by:IMB Dx, Inc. based inSeoul, SOUTH KOREA
AlphaLiquid®100 is a test that enables the detection of biomarkers which can predict the efficacy/resistance of targeted therapy for one blood test across 118 cancer-related genes. During cancer patients’ treatment journey, a simple blood draw can be used to support monitoring the treatment response and change the strategy when ...
Manufactured by:SD Biosensor based inSuwon-si, SOUTH KOREA
Blood collection vacuum tube which is used with STANDARD E TB-Feron ELISA for diagnosis of latent tuberculosis ...
Manufactured by:IMB Dx, Inc. based inSeoul, SOUTH KOREA
AlphaLiquid® Screening is a blood-based test for early detection of multiple cancers. With 10mL of blood, the test analyzes genetic and epigenetic features in cfDNA to screen for signals of cancer as well as predict the tissue of origin. ...
Manufactured by:iiSM Inc. based inSejong-si, SOUTH KOREA
A vein finder to show images of the blood vessels in real-time. Reveals the location and pattern of the blood vessels Non-invasive infrared detection technology makes it safe and hygienic. Can be used for infants elderly and emergency patients, etc ...
Manufactured by:PROTIA. iNC, formely known as ProteomeTech Inc. based inSeoul, SOUTH KOREA
ImmuneCheck IgG is an in vitro diagnostic kit for use in the semi-quantitative analysis of human IgG (hIgG) in human serum, plasma and whole blood samples using immunochromatography technology. " World's First" Human Immunoglobulin G Quantitative Analysis Rapid ...
Manufactured by:Crown Machinery, Inc. based inBaita District, CHINA
Crown machinery Blood separator is a kind of tubular separator that had unique design, specifically for the blood meal industry, widely used in pig, cattle, sheep, chicken, duck, goose and other animal blood of plasma and cell ...
Manufactured by:iiSM Inc. based inSejong-si, SOUTH KOREA
A vein finder to show imagesof the blood vesselsin real-time. Reveals the location and pattern of the blood vessels. Non-invasive infrared detectiontechnology makes it safe and hygienic. Can be used with a broad range! of patients; includinginfants,elderly and emergency ...
Manufactured by:Kangstem Biotech Co., Ltd. based inGangnam-gu, SOUTH KOREA
Kangstem Biotech is developing stem cell therapeutic products for patients suffering from rare and incurable diseases using umbilical cord blood-derived stem ...
Manufactured by:iiSM Inc. based inSejong-si, SOUTH KOREA
A vein finder to show images of the blood vessels in real-time. Reveals the location and pattern of the bloodvessels. Non-invasive infrared detection technology makes it safe and hygienic. Can be used with a broad range of patients including infants, elderly and emergency patients. ...
Manufactured by:GENCURIX based inGuro-gu, SOUTH KOREA
What is early diagnosis? Early diagnosis helps people to plan ahead while they are still able to make important decisions on their care and support needs and on financial and legal ...
Manufactured by:Pervice Korea Co., Ltd. based inSeoul, SOUTH KOREA
3E PRP is a patented innovative PRP product that can easily and quicklyextract highly concentrated PRP with only one kit. Contamination caused by exposure to air during blood collection and extraction has been ...
Manufactured by:IMB Dx, Inc. based inSeoul, SOUTH KOREA
Cell-free DNA (cfDNA) is circulating fragments of DNA that is released from cells into the circulatory system throughout the body. Tumor cells also release DNA into the blood stream, which is called circulation-tumor DNA(ctDNA). IMBdx Inc.’s AlphaLiquid® platform offers industry-leading ctDNA-based precision diagnostics solutions across the full continuum of cancer care, from therapy ...
Manufactured by:IMB Dx, Inc. based inSeoul, SOUTH KOREA
Tissue specimens are either from surgical resections or biopsies which may raise the risk of bleeding, and infection and further require recovery from the procedure. Genomic profiling of tissue samples provides a single point in space and time which is lacking the ability to reveal tumor heterogeneity and to test repeatedly to monitor the treatment efficacy. The risk of tissue biopsy is much ...